Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Population differences exist between the three trials, even though all focus on obesity and overweight without type 2 diabetes
J Burn Care Rehabil 23(2):8796 Cartotto R, Mayich M, Nickerson D, Gomez M (2008) SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center
Castellano-Castillo, D., et al
It should be noted that this conclusion is specific to anthropometric outcomes, as reproductive and endocrine parameters were not evaluated
For many patients with a BMI of around 45, a bariatric procedure may be the most suitable approach
Uninsured patients often cannot afford trial-and-error treatment approaches
US$ 26.34
US$ 25.94
US$ 25.51
